IMM 1.59% 31.0¢ immutep limited

prima biomed to release interim cvac clinical , page-33

  1. 1,716 Posts.
    lightbulb Created with Sketch. 65
    As stated many times by prima management, they have obviously taken note of dendreon stuff ups since the commercialization of Provenge. Thing to note is that the science was never the problem it was the management ! aslong as dendreon management never get near prima ( unless it's for a full takeover at multiples of current price ) we have no issue!
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.